Tag
For stage III colon cancers with a DNA-repair defect, adding the immunotherapy to standard chemotherapy halved the risk of the cancer returning. It is the first immunotherapy combination approved for use after surgery in this setting.
The Autus valve can be widened with a balloon catheter as a child grows, from toddler size to adult size — sparing some children born with heart defects from repeated open-heart surgeries.
Bristol Myers Squibb’s heart drug becomes the first of its class approved for adolescents with the inherited condition, a leading cause of sudden cardiac death in young people.
Tavapadon targets a narrower set of dopamine receptors than older drugs, aiming to ease movement symptoms with fewer of the side effects that make dopamine agonists hard to tolerate.
Children with idiopathic nephrotic syndrome have relied on steroids since the 1950s. Roche’s obinutuzumab is now approved to keep frequently relapsing patients in remission — offering a way off repeated steroid courses.
Efsitora alfa turns 365 basal insulin injections a year into 52. It is the second weekly insulin cleared in the US this year — and a sign that diabetes care is shifting toward fewer, longer-acting doses.
An FDA advisory panel voted that the benefits of Grail’s Galleri outweigh its risks — but a split vote on effectiveness, and a missed goal in a major UK trial, show how much is still unsettled.